Loading...

Chembio Diagnostics, Inc.

CEMI•NASDAQ
Healthcare
Medical - Diagnostics & Research
$0.46
$0.001(0.22%)

Chembio Diagnostics, Inc. (CEMI) Stock Overview

Explore Chembio Diagnostics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 60.0/100

Key Financials

Market Cap16.7M
P/E Ratio-0.47
EPS (TTM)$-0.72
ROE-0.89%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$0.13

CEMI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Chembio Diagnostics, Inc. (CEMI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.13.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.47 and a market capitalization of 16.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
1.56%
6-Month Change
42.41%
Year-to-Date (YTD) Change
80.20%
1-Year Change
-32.55%
3-Year Change
-95.35%
5-Year Change
-95.24%
All-Time (Max) Change
-99.98%

Contact Information

https://chembio.com
631 924 1135
555 Wireless Boulevard, Hauppauge, NY, 11788

Company Facts

188 Employees
IPO DateOct 18, 2000
CountryUS

Frequently Asked Questions

;